Original language | English |
---|---|
Pages (from-to) | e95-e96 |
Journal | The Lancet Rheumatology |
Volume | 3 |
Issue number | 2 |
Early online date | 2021 |
DOIs |
|
Publication status | Published - Feb 2021 |
Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply
Research output: Contribution to journal › Comment/Letter to the editor › Academic
2
Citations
(Scopus)